Alumis Stock (NASDAQ: ALMS) stock price, news, charts, stock research, profile.
You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.
Other companies in Alumis’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Alumis has a consensus price target of $29.60.
The stock price for Alumis (NASDAQ: ALMS) is $10 last updated November 19, 2024 at 7:37 AM EST.
There are no upcoming dividends for Alumis.
Alumis’s Q4 earnings are confirmed for Saturday, February 15, 2025.
There is no upcoming split for Alumis.
Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.